Unknown

Dataset Information

Identification and validation of an immune signature associated with EMT and metabolic reprogramming for predicting prognosis and drug response in bladder cancer.


ABSTRACT:

Background

Epithelial-mesenchymal transition (EMT), one leading reason of the dismal prognosis of bladder cancer (BLCA), is closely associated with tumor invasion and metastasis. We aimed to develop a novel immune-related gene signature based on different EMT and metabolic status to predict the prognosis of BLCA.

Methods

Gene expression and clinical data were obtained from TCGA and GEO databases. Patients were clustered based on EMT and metabolism scores calculated by ssGSEA. The immune-related differentially expressed genes (DEGs) between the two clusters with the most obvious differences were used to construct the signature by LASSO and Cox analysis. Time-dependent receiver operating characteristic (ROC) curves and Kaplan-Meier curves were utilized to evaluate the gene sig

SUBMITTER: Zhang Z 

PROVIDER: S-EPMC9359097 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature